Trial Profile
Efficacy and Tolerance of Parecoxib for Prevention of Catheter-related Bladder Discomfort in Patients Undergoing Catheterization After TURBT: A Prospective, Randomized, Placebo-controlled, Double-blind Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Oct 2016
Price :
$35
*
At a glance
- Drugs Parecoxib (Primary)
- Indications Bladder disorders; Postoperative pain
- Focus Therapeutic Use
- 16 Oct 2016 Status changed from recruiting to completed.
- 11 Apr 2016 New trial record